delphinidin has been researched along with Myeloproliferative Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinkus, GS; Pinkus, JL | 1 |
| Bindl, JM; Butmarc, JR; Pinkus, GS; Said, JW; Shintaku, P; Stoll, PN | 1 |
| Magyarlaki, T | 1 |
1 review(s) available for delphinidin and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Possibility of using monoclonal antibodies on formalin-paraffin sections].
Topics: Antibodies, Monoclonal; Bone Marrow; Formaldehyde; Histological Techniques; Humans; Immunoenzyme Techniques; Lymph Nodes; Myeloproliferative Disorders; Paraffin | 1988 |
2 other study(ies) available for delphinidin and Myeloproliferative Disorders
| Article | Year |
|---|---|
Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
Topics: Biomarkers, Tumor; Bone Marrow; Fixatives; Hematologic Diseases; Histological Techniques; Humans; Immunohistochemistry; Myeloproliferative Disorders; Neoplasms; Paraffin; Peroxidase; Reference Values; Sensitivity and Specificity; Staining and Labeling | 1991 |
Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Topics: Antibodies, Monoclonal; B-Lymphocytes; Biomarkers, Tumor; Cell Transformation, Neoplastic; Hodgkin Disease; Humans; Immunohistochemistry; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Myeloproliferative Disorders; Paraffin; T-Lymphocytes | 1989 |